Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
Therapeutic drug monitoring (TDM) of conventional cytotoxic chemotherapies is strongly supported yet poorly implemented in daily practice in hospitals. Analytical methods for the quantification of cytotoxic drugs are instead widely presented in the scientific literature, while the use of these thera...
Main Authors: | Myriam Briki, Pascal André, Yann Thoma, Nicolas Widmer, Anna D. Wagner, Laurent A. Decosterd, Thierry Buclin, Monia Guidi, Sandro Carrara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1283 |
Similar Items
-
From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
by: Sylvain Goutelle, et al.
Published: (2023-03-01) -
Population Pharmacokinetics in Oncology and Its Clinical Applications
by: Nicolas Widmer, et al.
Published: (2024-05-01) -
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
by: Sylvain Goutelle, et al.
Published: (2022-10-01) -
Estimation of US patients with cancer who may respond to cytotoxic chemotherapy
by: Edward B Maldonado, et al.
Published: (2020-09-01) -
Pediatric oncology drug development and dosage optimization
by: S. Y. Amy Cheung, et al.
Published: (2024-01-01)